Nov 13 (Reuters)-
Shin Nippon Biomedical Laboratories Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2015 Sep 30, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6.56 8.05 15.73
(-18.5 pct) (+3.0 pct) (-11.8 pct)
Operating loss 2.39 loss 869 mln loss 1.98
Recurring loss 2.64 loss 522 mln loss 2.67
Net 1.03 loss 759 mln 108 mln
EPS 25.83 yen loss 19.08 yen 2.71 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Shin Nippon Biomedical Laboratories Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T
((Tokyo Headline News Desk +813 6441 1812))